Wire · opportunities
FDA Clears CCTA-Based AI Software for Facilitating Management of Coronary Artery Disease
◆ Sectors
Medtech
◆ Geography
United States
◆ Source
◆ Verified
Fusion42 · 19 November 2026 · Fusion42 review
The FDA granted 510(k) clearance to Syngo.CT Coronary Cockpit, an AI software by Siemens Healthineers that automates analysis of coronary plaque from CCTA scans and supports planning of coronary interventions.
This Wire brief sits within Fusion42's coverage of Medtech.
◆ ◆ The Wire takeaway
You can now build clinical workflows incorporating FDA-cleared AI for coronary plaque analysis, creating new diagnostic tools and intervention planning aids in cardiology imaging.
◆ Coverage
1 source · 19 Nov 2026
◆ Related on Wire
◆ Topics
MedtechFDA-clearanceAI-softwarecoronary-artery-diseasemedical-imagingCCTA